These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 30306435)

  • 1. Promoting 'Equitable Access' to PrEP in Australia: Taking Account of Stakeholder Perspectives.
    Newman C; Hughes S; Persson A; Truong HM; Holt M
    AIDS Behav; 2019 Jul; 23(7):1846-1857. PubMed ID: 30306435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "No-one's driving this bus" - qualitative analysis of PrEP health promotion for Aboriginal and Torres Strait Islander gay and bisexual men.
    Hope A; Haire B
    Aust N Z J Public Health; 2019 Feb; 43(1):18-23. PubMed ID: 30516311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of providing HIV pre-exposure prophylaxis across Australian clinics: qualitative insights of clinicians.
    Smith AKJ; Haire B; Newman CE; Holt M
    Sex Health; 2021 May; 18(2):187-194. PubMed ID: 33906719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troubling the non-specialist prescription of HIV pre-exposure prophylaxis (PrEP): the views of Australian HIV experts.
    Smith AKJ; Holt M; Hughes SD; Truong HM; Newman CE
    Health Sociol Rev; 2020 Mar; 29(1):62-75. PubMed ID: 33411659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian interdisciplinary healthcare providers' perspectives on the effects of broader pre-exposure prophylaxis (PrEP) access on uptake and service delivery: a qualitative study.
    Lazarou M; Fitzgerald L; Warner M; Downing S; Williams OD; Gilks CF; Russell D; Dean JA
    Sex Health; 2020 Dec; 17(6):485-492. PubMed ID: 33292927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Attitudes to and the Use of HIV Pre-exposure Prophylaxis by Australian Gay and Bisexual Men, 2011-2017: Implications for Further Implementation from a Diffusion of Innovations Perspective.
    Holt M; Lea T; Bear B; Halliday D; Ellard J; Murphy D; Kolstee J; de Wit J
    AIDS Behav; 2019 Jul; 23(7):1939-1950. PubMed ID: 30539496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011-2015.
    Holt M; Lea T; Schmidt HM; Kolstee J; Ellard J; Murphy D; Truong HH; de Wit J
    Sex Transm Infect; 2017 Sep; 93(6):438-444. PubMed ID: 28108701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Resource Challenges to Integrating HIV Pre-Exposure Prophylaxis (PrEP) into the Public Health System in Kenya: A Qualitative Study.
    Mack N; Wong C; McKenna K; Lemons A; Odhiambo J; Agot K
    Afr J Reprod Health; 2015 Mar; 19(1):54-62. PubMed ID: 26103695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study.
    Siemieniuk RA; Sivachandran N; Murphy P; Sharp A; Walach C; Placido T; Bogoch II
    AIDS Patient Care STDS; 2015 Aug; 29(8):431-6. PubMed ID: 26154174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
    BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
    Idoko J; Folayan MO; Dadem NY; Kolawole GO; Anenih J; Alhassan E
    BMC Public Health; 2015 Apr; 15():349. PubMed ID: 25881087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".
    Hoffman S; Guidry JA; Collier KL; Mantell JE; Boccher-Lattimore D; Kaighobadi F; Sandfort TG
    J Int Assoc Provid AIDS Care; 2016; 15(1):59-65. PubMed ID: 26293904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-negative male couples' attitudes about pre-exposure prophylaxis (PrEP) and using PrEP with a sexual agreement.
    Mitchell JW; Lee JY; Woodyatt C; Bauermeister J; Sullivan P; Stephenson R
    AIDS Care; 2016 Aug; 28(8):994-9. PubMed ID: 27055001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From evidence to action: challenges for the Brazilian Unified National Health System in offering pre-exposure prophylaxis (PrEP) for HIV to persons with the greatest vulnerability].
    Zucchi EM; Grangeiro A; Ferraz D; Pinheiro TF; Alencar T; Ferguson L; Estevam DL; Munhoz R;
    Cad Saude Publica; 2018 Jul; 34(7):e00206617. PubMed ID: 30043853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
    Adams LM; Balderson BH
    AIDS Care; 2016 Sep; 28(9):1154-8. PubMed ID: 26915281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US.
    Underhill K; Morrow KM; Colleran CM; Holcomb R; Operario D; Calabrese SK; Galárraga O; Mayer KH
    PLoS One; 2014; 9(11):e112425. PubMed ID: 25386746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
    Chakrapani V; Newman PA; Shunmugam M; Mengle S; Varghese J; Nelson R; Bharat S
    AIDS Patient Care STDS; 2015 Oct; 29(10):569-77. PubMed ID: 26348459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.